Contract award · 26 Oct 2026

Drug Discovery Advancement Consultancy

University Of Edinburgh awarded “Drug Discovery Advancement Consultancy” to Future Bio Consulting Ltd for £286k. Awarded without open competition.

No competitionResearch & developmentScotland

Value £286k

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
University Of Edinburgh · Body governed by public law
Value
£286,440
Procedure
Award procedure without prior publication of a call for competition
Sector
Research & development · Research and development services and related consultancy services (CPV 73000000)
Region
Scotland
Timeline
  1. Contract date26 Oct 2026
  2. Published28 Oct 2026Published 2 days after the contract date

Description

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.

About the supplier

More from University Of Edinburgh

All contracts

Recent research & development contracts

Sector overview